Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuti…
- Recall date
- March 3, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0384-2026
- FDA classification
- Class II
- Brand / firm
- Rising Pharma Holding, Inc.
- Sold / distributed
- Nationwide within the U.S
Why it was recalled
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.
Get recall alerts
Free email alert whenever Rising Pharma Holding, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Rising Pharma Holding, Inc.